Ameriprise Financial Inc. Sells 22,550 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Ameriprise Financial Inc. lowered its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 16.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 114,178 shares of the company's stock after selling 22,550 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.76% of U.S. Physical Therapy worth $10,129,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of USPH. Northern Trust Corp raised its position in shares of U.S. Physical Therapy by 13.9% in the 4th quarter. Northern Trust Corp now owns 261,825 shares of the company's stock worth $23,226,000 after acquiring an additional 32,024 shares in the last quarter. Tudor Investment Corp ET AL raised its position in shares of U.S. Physical Therapy by 9.7% in the 4th quarter. Tudor Investment Corp ET AL now owns 16,792 shares of the company's stock worth $1,490,000 after acquiring an additional 1,490 shares in the last quarter. Aquatic Capital Management LLC raised its position in shares of U.S. Physical Therapy by 18.0% in the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after acquiring an additional 198 shares in the last quarter. Susquehanna Fundamental Investments LLC bought a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $859,000. Finally, Dark Forest Capital Management LP bought a new position in shares of U.S. Physical Therapy in the 4th quarter worth approximately $247,000.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock traded down $1.83 during trading hours on Thursday, hitting $75.45. The company's stock had a trading volume of 107,434 shares, compared to its average volume of 111,299. The business has a 50 day moving average price of $71.96 and a two-hundred day moving average price of $83.49. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $102.89. The company has a market cap of $1.15 billion, a PE ratio of 80.26, a PEG ratio of 3.54 and a beta of 1.44. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $183.79 million for the quarter, compared to analysts' expectations of $176.78 million. During the same period in the previous year, the firm posted $0.51 earnings per share. The business's revenue was up 18.0% compared to the same quarter last year. Analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be issued a $0.45 dividend. The ex-dividend date of this dividend is Friday, May 23rd. This represents a $1.80 annualized dividend and a dividend yield of 2.39%. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. The trade was a 19.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.00% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Thursday, May 8th. JMP Securities reaffirmed a "market outperform" rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. JPMorgan Chase & Co. cut their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Finally, Barrington Research lowered their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.